Success of Platinum Desensitization 'Depends on the Agent'Success of Platinum Desensitization 'Depends on the Agent'

Cancer patients receiving oxaliplatin are more likely to experience hypersensitivity reactions during desensitization than those given carboplatin. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news